103273-65-0 Usage
Uses
Used in Pharmaceutical Research and Development:
1-(3-Chlorophenyl)-2-Methylpropan-2-aMine is used as a research compound for the development of new medications and drugs, particularly in the field of neuroscience and pharmacology. It aids in understanding the effects of stimulants on the central nervous system and their potential applications in treating various conditions.
Used in Neuroscience Research:
In the field of neuroscience, 1-(3-Chlorophenyl)-2-Methylpropan-2-aMine is used as a research tool to study the mechanisms of action of stimulants on the brain. This helps in gaining insights into mood, cognition, and behavior alterations caused by such compounds.
Used in Regulatory and Control Measures:
Due to its potential for abuse and dependence, 1-(3-Chlorophenyl)-2-Methylpropan-2-aMine is often subject to regulatory and control measures. It is used in the development of policies and guidelines for the safe and responsible use of such substances in medical and research settings.
Used in Ongoing Pharmacological Research:
1-(3-Chlorophenyl)-2-Methylpropan-2-aMine is employed in ongoing pharmacological research to further understand its effects and explore its potential therapeutic uses. This includes investigating its interactions with various biological systems and identifying possible applications in treating specific conditions or disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 103273-65-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,2,7 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 103273-65:
(8*1)+(7*0)+(6*3)+(5*2)+(4*7)+(3*3)+(2*6)+(1*5)=90
90 % 10 = 0
So 103273-65-0 is a valid CAS Registry Number.
103273-65-0Relevant academic research and scientific papers
Direct Access to Primary Amines from Alkenes by Selective Metal-Free Hydroamination
Du, Yi-Dan,Chen, Bi-Hong,Shu, Wei
supporting information, p. 9875 - 9880 (2021/03/29)
Direct and selective synthesis of primary amines from easily available precursors is attractive yet challenging. Herein, we report the rapid synthesis of primary amines from alkenes via metal-free regioselective hydroamination at room temperature. Ammonium carbonate was used as ammonia surrogate for the first time, allowing for efficient conversion of terminal and internal alkenes into linear, α-branched, and α-tertiary primary amines under mild conditions. This method provides a straightforward and powerful approach to a wide spectrum of advanced, highly functionalized primary amines which are of particular interest in pharmaceutical chemistry and other areas.
HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
-
Page 77, (2010/02/07)
The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.
